A Case of ALK+ Anaplastic Large T Cell Lymphoma (ALCL) with Lymphomatous Meningitis

Blood ◽  
2011 ◽  
Vol 118 (21) ◽  
pp. 5226-5226
Author(s):  
Bongi A. Rudder ◽  
Nidhi Mishra ◽  
Albert S. Braverman ◽  
Michael Geraghty ◽  
Elpidio Jimenez

Abstract Abstract 5226 Background: Anaplastic large T cell lymphoma may present with indolent cutaneous T cell infiltration, progressing to more aggressive skin disease and systemic involvement. In adults lymphomatous meningitis is very rare complication. Case Report: A 62 year old Jamaican woman had been diagnosed with biopsy proven psoriasis when 42 years of age. Ustekinumab had been initiated without effect two months prior to her presentation to us. A new cutaneous nodule on her left neck was then found, shave biopsy of which revealed psoriasiform dermatitis with epidermotropism, suspicious for early patch stage mycosis fungoides. The lesion was CD30+, suggestive of ALCL and was positive for ALK. Positron emission tomography revealed an SUV of 6.0 in the neck mass, but lymph nodes in all regions had an SUV of <2.3. Axillary lymph node biopsy, bone marrow biopsy and flow cytometry were negative. Local electron beam radiation was administered to the left supraclavicular space with complete resolution of the cutaneous nodule. About 2 months following completion of radiation therapy she noted anorexia, 30 lb weight loss, night sweats and left hip pain. Physical examination revealed a sick woman, with whole body scaling red-brown macules and plaques. CBC was normal except for Hb of 10 g/dl, platelets 453,000/dl. Hepatic and renal function studies were normal. ESR was 84 mm/hr, lactic dehydrogenase 670 IU (reference range 300–600 IU) and calcium 15.1 mg/dl. HTLV1, HIV, hepatitis panel and anti-nuclear antibody serologies were negative. Computer automated tomography of the pelvis demonstrated 6×2×8 cm soft tissue mass on the sacrum invading left sacro-iliac joint and ilium. Biopsy revealed ALCL, positive for CD43, CD2dim, CD7dim, CD30, and nuclear and cytoplasmic ALK1, while negative for CD43, 3, 4, 5, 8, 19,20, 34, 138, PAX5, AE1/AE3, Cam5, S100 and TdT. The mass was irradiated with alleviation of pain, but cutaneous nodules progressively appeared and continuous fever developed with negative blood cultures. There was increasing confusion, blurred vision and bilateral abducens paralysis. Magnetic resonance imaging of the head and spine revealed dural enhancement and multiple extra- and intercranial interosseous masses, one of which involved the posterior sella turcica. Cyclophosphamide, doxorubicin, vincristine and prednisone were initiated; lumbar puncture was refused. Within 2 days after treatment initiation the cutaneous nodules disappeared, fever subsided, the left abducens palsy resolved completely while the right improved. Conclusion: Our patient's long standing indolent skin disease abruptly progressed to cutaneous and systemic ALCL, with evidence of lymphomatous meningitis. The response of her abducens palsies and other CNS findings to systemic chemotherapy alone suggests that her meningeal involvement may have arisen from that of adjacent bones. Involvement of CNS in ALK positive systemic anaplastic large cell lymphoma is rare and reported in mainly pediatric cases. Disclosures: No relevant conflicts of interest to declare.

2013 ◽  
Vol 2013 ◽  
pp. 1-11 ◽  
Author(s):  
Chen-Hsi Hsieh ◽  
Pei-Wei Shueng ◽  
Shih-Chiang Lin ◽  
Hui-Ju Tien ◽  
An-Cheng Shiau ◽  
...  

A 36-year-old woman was diagnosed with a therapy-refractory cutaneous CD4+ T-cell lymphoma, T3N0M0B0, and stage IIB. Helical irradiation of the total skin (HITS) and dose painting techniques, with 30 Gy in 40 fractions interrupted at 20 fractions with one week resting, 4 times per week were prescribed. The diving suit was dressed whole body to increase the superficial dose and using central core complete block (CCCB) technique for reducing the internal organ dose. The mean doses of critical organs of head, chest, and abdomen were 2.1 to 29.9 Gy, 2.9 to 8.1 Gy, and 3.6 to 15.7 Gy, respectively. The mean dose of lesions was 84.0 cGy. The dosage of left side pretreated area was decreased 57%. The tumor regressed progressively without further noduloplaques. During the HITS procedure, most toxicity was grade I except leukocytopenia with grade 3. No epitheliolysis, phlyctenules, tumor lysis syndrome, fever, vomiting, dyspnea, edema of the extremities, or diarrhea occurred during the treatment. HITS with dose painting techniques provides precise dosage delivery with impressive results, sparing critical organs, and offering limited transient and chronic sequelae for previously locally irradiated, therapy-refractory cutaneous T-cell lymphoma.


2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Ying Zhang ◽  
Kuansong Wang ◽  
Qian Tan ◽  
Keda Yang ◽  
Dengshu Wu ◽  
...  

Abstract Background We present a unique case of primary breast CD20-positive extranodal NK/T cell lymphoma with stomach involvement in a young Chinese female patient. Case presentation The patient presented with a mass in her right breast that rapidly increased in size over approximately 2 months. Upper gastrointestinal endoscopy showed a giant serpentine ulcer in the stomach. Biopsy was performed, and microscopic inspection revealed that the fibrous tissue was diffusely involved by medium to large abnormal lymphocytes. The cytoplasm was low to moderate. The tumor cells had irregular nuclei and inconspicuous nucleoli. The lymphoid cells were strongly immunoreactive to CD20, CD3, CD4, CD56, TIA-1, EBER, and Ki-67 (90%). Epstein-Barr virus genomes were also found in tumor cells by in situ hybridization. A whole-body positron emission tomography (PET)-CT scan revealed intense FDG uptake in the right breast and greater curvature of the stomach. Monoclonal rearrangements of the T cell receptor (TCR-γ) and immunoglobulin heavy chain (IgH) were identified by genetic analysis. Whole-genome next-generation sequencing was performed, and up to 12 gene mutations, including a frameshift mutation in exon 4 of the BCOR (G97Rfs*87; 44.3%) gene and a base substitution mutation (Q61H 17.6%) in exon 3 of the KRAS gene, were detected. Kyoto Encyclopedia of Genes and Genomes pathway analyses were performed using the database for annotation, visualization, and integrated discovery, which showed that rare primary breast CD20-positive extranodal NK/T cell lymphoma had a unique genetic background compared with diffuse large B cell lymphoma and extranodal NK/T cell lymphoma without CD20 expression. The patient received four cycles of the modified SMILE regimen. The second whole-body PET-CT scan revealed that the right breast mass was significantly smaller than before; additionally, FDG uptake in the stomach wall disappeared. Conclusions Systemic examination, extensive immunohistochemistry, and molecular profiling are essential for an accurate diagnosis. More similar cases are required to clarify the biological pathways and even the potential molecular mechanisms of rare lymphomas, which may help direct further treatment.


2008 ◽  
Vol 39 (1) ◽  
pp. 57-61 ◽  
Author(s):  
Gye-Yeon Lim ◽  
Seung Tae Hahn ◽  
Nak Gyun Chung ◽  
Hack Ki Kim

2005 ◽  
Vol 59 (5) ◽  
pp. 566 ◽  
Author(s):  
Seung Hyeun Lee ◽  
Eun Sil Ha ◽  
Jung Ha Kim ◽  
Jin Yong Jung ◽  
Kyung Joo Lee ◽  
...  

Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 2404-2404
Author(s):  
Barbara Pro ◽  
Rodolfo F. Nunez ◽  
Jorge Romaguera ◽  
Maria A. Rodriguez ◽  
Fredrick Hagemeister ◽  
...  

Abstract Background: T-cell non-Hodgkin’s lymphomas represent approximately 12% of all lymphomas and in general are associated with a worse prognosis compared to their B-cell counterparts. In patients with Hodgkin’s disease and aggressive B-cell lymphoma (18F)fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) represents an important early prognostic tool for predicting outcome. Very little information is available regarding the role of FDG-PET in T-cell lymphoma. Patients and Methods: A total of 20 patients with newly diagnosed and histologically proven T/NK cell lymphomas where staged with both conventional methods and whole-body PET scanning. Patients underwent FDG-PET, concurrently with CT of neck, chest, abdomen, and pelvis within 3 weeks prior to induction treatment, after 2–4 cycles, and after the end of induction. All patients but three received HCVIDDoxil, using pegylated liposomal doxorubicin as a substitute for doxorubicin in the HyerCVAD regimen, alternating with methotrexate and cytarabine. Three patients received the standard CHOP (cyclophosphamide,hydroxydaunomycin, vincristine, prednisone) regimen. According to the International Prognostic Index (IPI), 35% of patients were stratified as low risk, 25% as low/intermediate, 35% as high/intermediate, and 5% as high risk. Baseline scans were strongly positive in all patients. Results: During induction therapy (at 2–4 cycles) FDG-PET became negative in 16 (80%) patients and remained positive in 4 (20%) patients. Twelve out of 16 (75%) patients who were PET negative during induction therapy relapsed, and four out of four (100%) in the PET positive group. Two of the “ early” PET negative patients became positive after 4 cycles. Median progression-free survival was 240 days in the PET negative group and 85 days in the PET positive group (Log-rank p=0.07). Conclusions: In this limited number of patients homogeneously treated with newly diagnosed T cell lymphomas the assessment of metabolic activity by FDG-PET during induction therapy did not predict long-term prognosis.


2018 ◽  
Vol 2018 ◽  
pp. 1-6
Author(s):  
Joy Tao ◽  
Courtney Hentz ◽  
Michael L. Mysz ◽  
Issra Rashed ◽  
David Eilers ◽  
...  

Cutaneous T-cell lymphoma (CTCL) is a chronic, debilitating disease that has a severe impact on quality of life. We present a patient with multiple CTCL lesions on the bilateral feet, which impaired his ability to ambulate. His lesions on both feet were successfully treated with a total of 8 Gy in two fractions via high-dose-rate surface brachytherapy using the Freiburg Flap applicator. The deeper aspects of the bulkier lesions on the left foot were boosted with electron beam therapy. The radiation therapy was well tolerated, and the patient was able to regain his mobility after completing radiation therapy. To our knowledge, there are few reports utilizing brachytherapy in treating CTCL. Our case describes treatment of larger, more extensive CTCL lesions than previously reported.


Sign in / Sign up

Export Citation Format

Share Document